Sign In
Buy ORMP
$4.07
-0.0500 (-1.21%)
At Close: Jul 31, 2026
US Stocks Turn Higher; Dow Jumps 200 Points
05:11pm, Thursday, 12'th Jan 2023 Benzinga
U.S. stocks turned higher midway through trading, following the release of inflation data.
The Dow traded up 0.62% to 34,182.79 while the NASDAQ rose 0.28% to 10,962.67. The S&P 500 also rose, gaining
Why Oramed Pharmaceuticals Stock Is Crashing Today
04:50pm, Thursday, 12'th Jan 2023 The Motley Fool
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
Dow Drops 150 Points; US Inflation Rate Slows In December
02:54pm, Thursday, 12'th Jan 2023 Benzinga
U.S. stocks traded lower this morning, following the release of inflation data.
Following the market opening Thursday, the Dow traded down 0.45% to 33,819.93 while the NASDAQ fell 0.85% to 10,838.48.
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
12:54pm, Thursday, 12'th Jan 2023 Benzinga
Gainers
Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.
Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares rose
Why Oramed Pharmaceuticals Stock Is Crashing Today
11:50am, Thursday, 12'th Jan 2023
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market Session
11:01am, Thursday, 12'th Jan 2023 Benzinga
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares dipped 70.3% to $3.1
Why Is Oramed (ORMP) Stock Down 75% Today?
10:44am, Thursday, 12'th Jan 2023
Oramed (NASDAQ: ORMP ) stock is falling hard on Thursday after releasing data from a Phase 3 clinical trial. This clinical trial saw Oramed testing the efficiency of ORMD-0801 in patients with Type 2
Oramed's oral insulin pill fails; stock is down 72%
08:02am, Thursday, 12'th Jan 2023
Shares of Oramed Pharmaceuticals Inc. ORMP, +5.78% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or second
Jim Cramer Says Avoid This Stock: 'Too Expensive'
03:35pm, Thursday, 05'th Jan 2023 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money. "Those are the ones I’m trying to get people to s
Li Auto, XPeng, Nio And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:15am, Tuesday, 03'rd Jan 2023 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Gorilla Technology Group Inc. (NASDAQ: GRRR) shares surged 162% to $2
Oramed: NASH Biotech Play With Added Bonus
03:49am, Wednesday, 07'th Dec 2022
Oramed achieved positive results from phase 2 study using ORMD-0801 for Type 2 Diabetes patients with NASH. Primary safety endpoint and secondary exploratory biomarker endpoints established proof of c
Oramed: Oral Insulin For Type 2 Diabetes May Become A Reality
05:52am, Wednesday, 21'st Sep 2022
Results from Oramed Pharmaceuticals's first phase 3 study ORA-D-013-1, using ORMD-0801 for the treatment of patients with Type 2 Diabetes, is expected January 2023. Results from the ongoing Cohorts A
Why Oramed Pharmaceuticals Stock Is On Fire Today
06:22pm, Tuesday, 12'th Jul 2022 The Motley Fool
The biotech's stock has been ripping higher of late.
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
04:00pm, Tuesday, 12'th Jul 2022 Benzinga
Gainers
Canoo Inc. (NASDAQ: GOEV) shares jumped 79.9% to $4.2627 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Life
Why Oramed Pharmaceuticals Stock Is On Fire Today
02:22pm, Tuesday, 12'th Jul 2022
The biotech's stock has been ripping higher of late.
